INCOMING! New PepMix Peptide Pools for M. Tuberculosis!
Published on 26/01/2023
Mycobacterium tuberculosis causes 1.5 million deaths world-wide annually. With antibiotic and drug resistant tuberculosis being on the rise, close epidemiological monitoring, drug and vaccine development, and diagnostic tests to also detect resistance are imperative in combatting its spread.
To profile antigen-specific T cell immune responses, we have updated out M. tuberculosis catalog with many currently relevant PepMix peptide pools, to complete our portfolio.
The new PepMixes cover the antigens for secretion system -, secretion-associated, and extracellular immunogenic proteins:
- M. tuberculosis EspA
- M. tuberculosis EsxN
- M. tuberculosis Mpt64
- M. tuberculosis PPE68
- M. tuberculosis TB8.4